Award

Repurposing mTOR inhibitors to boost vaccine responses in the immunocompromised and elderly

Description: The immune system declines with age, and is further impaired by age-related comorbidities and immune-suppressive medications. Because of this, infections that are prevented by vaccination in the general population were the third leading cause of Years of Life Lost in Australians over 65 last year. This project will repurpose a medication called rapamycin; a pill to be taken at the time of vaccination by older and immunocompromised Australians to significantly improve immunity against infection.
Amount: A$1,320,000
Funding type: research
Funder scheme: Medical Research Future Fund
Start date: 2024-03-01
End date: 2028-02-29
Subfield: Immunology
Funded outputs count: 0
Funder award ID: GA360291
OpenAlex ID: G5076023053